BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36361531)

  • 21. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.
    Beach JA; Aspuria PJ; Cheon DJ; Lawrenson K; Agadjanian H; Walsh CS; Karlan BY; Orsulic S
    Oncotarget; 2016 Jan; 7(4):4167-82. PubMed ID: 26716409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.
    Tauseef M; Kini V; Knezevic N; Brannan M; Ramchandaran R; Fyrst H; Saba J; Vogel SM; Malik AB; Mehta D
    Circ Res; 2008 Nov; 103(10):1164-72. PubMed ID: 18849324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation.
    Hirata N; Yamada S; Shoda T; Kurihara M; Sekino Y; Kanda Y
    Nat Commun; 2014 Sep; 5():4806. PubMed ID: 25254944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
    Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
    Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ.
    Chen J; Wang W; Qi Y; Kaczorowski D; McCaughan GW; Gamble JR; Don AS; Gao X; Vadas MA; Xia P
    Biochim Biophys Acta; 2016 Feb; 1861(2):138-147. PubMed ID: 26615875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins.
    Harijith A; Pendyala S; Reddy NM; Bai T; Usatyuk PV; Berdyshev E; Gorshkova I; Huang LS; Mohan V; Garzon S; Kanteti P; Reddy SP; Raj JU; Natarajan V
    Am J Pathol; 2013 Oct; 183(4):1169-1182. PubMed ID: 23933064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine kinase 1/S1P pathway involvement in the GDNF-induced GAP43 transcription.
    Murakami M; Ito H; Hagiwara K; Kobayashi M; Hoshikawa A; Takagi A; Kojima T; Tamiya-Koizumi K; Sobue S; Ichihara M; Suzuki M; Banno Y; Nozawa Y; Murate T
    J Cell Biochem; 2011 Nov; 112(11):3449-58. PubMed ID: 21769916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling.
    Li J; Wu H; Li W; Yin L; Guo S; Xu X; Ouyang Y; Zhao Z; Liu S; Tian Y; Tian Z; Ju J; Ni B; Wang H
    Oncogene; 2016 Oct; 35(42):5501-5514. PubMed ID: 27065335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway.
    Wang X; Zhang DM; Gu TT; Ding XQ; Fan CY; Zhu Q; Shi YW; Hong Y; Kong LD
    Biochem Pharmacol; 2013 Dec; 86(12):1791-804. PubMed ID: 24134913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells.
    González-Fernández B; Sánchez DI; Crespo I; San-Miguel B; Álvarez M; Tuñón MJ; González-Gallego J
    Biofactors; 2017 Mar; 43(2):272-282. PubMed ID: 27801960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.
    Kohno M; Momoi M; Oo ML; Paik JH; Lee YM; Venkataraman K; Ai Y; Ristimaki AP; Fyrst H; Sano H; Rosenberg D; Saba JD; Proia RL; Hla T
    Mol Cell Biol; 2006 Oct; 26(19):7211-23. PubMed ID: 16980623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect and mechanism of sphingosine kinase-1 knockdown on non-small cell lung cancer cell proliferation and mitochondrial apoptotic pathway].
    Cao YH; Yin W; Lyu YR
    Sheng Li Xue Bao; 2021 Dec; 73(6):893-900. PubMed ID: 34961863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
    Tanfin Z; Serrano-Sanchez M; Leiber D
    Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion.
    Lv M; Zhang D; Dai D; Zhang W; Zhang L
    Inflamm Res; 2016 Jul; 65(7):551-62. PubMed ID: 27002656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis.
    Liu XT; Huang Y; Liu D; Jiang YC; Zhao M; Chung LH; Han XD; Zhao Y; Chen J; Coleman P; Ting KK; Tran C; Su Y; Dennis CV; Bhatnagar A; Liu K; Don AS; Vadas MA; Gorrell MD; Zhang S; Murray M; Kavurma MM; McCaughan GW; Gamble JR; Qi Y
    J Transl Med; 2024 Jan; 22(1):43. PubMed ID: 38200582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway.
    Huang J; Huang K; Lan T; Xie X; Shen X; Liu P; Huang H
    Mol Cell Endocrinol; 2013 Jan; 365(2):231-40. PubMed ID: 23127801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.
    Chen MH; Yen CC; Cheng CT; Wu RC; Huang SC; Yu CS; Chung YH; Liu CY; Chang PM; Chao Y; Chen MH; Chen YF; Chiang KC; Yeh TS; Chen TC; Huang CY; Yeh CN
    Oncotarget; 2015 Sep; 6(27):23594-608. PubMed ID: 26090720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer.
    Zhang S; Chen X; Wu C; Xu H; Xie X; Feng M; Hu S; Bai H; Gao F; Tong L; Ding J; Liu H; Xie Z; Wang J
    J Med Chem; 2022 Jun; 65(11):7697-7716. PubMed ID: 35439002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sphingosine kinase 1 in viral infections.
    Carr JM; Mahalingam S; Bonder CS; Pitson SM
    Rev Med Virol; 2013 Mar; 23(2):73-84. PubMed ID: 22639116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.